1. Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug. Issue 2 (18th September 2013) Authors: Vieira, Md L T; Kirby, B; Ragueneau‐Majlessi, I; Galetin, A; Chien, J Y L; Einolf, H J; Fahmi, O A; Fischer, V; Fretland, A; Grime, K; Hall, S D; Higgs, R; Plowchalk, D; Riley, R; Seibert, E; Skordos, K; Snoeys, J; Venkatakrishnan, K; Waterhouse, T; Obach, R S Journal: Clinical pharmacology & therapeutics Issue: Volume 95:Issue 2(2014) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Evacetrapib Administered as Monotherapy or in Combination With Statins. (22nd January 2014) Authors: Friedrich, S; Kastelein, JJP; James, D; Waterhouse, T; Nissen, SE; Nicholls, SJ; Krueger, KA Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 3:Number 1(2014) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗